In your opinion (and anyone's)can we be optimistic about some good news sooner rather than later because of the multiple deals? And if we do get news on only one of the drugs, will be rise in share price be less dramatic--as in not the $25 or higher that I used to see mentioned here? On the other hand, closing one deal could give the company credibility and more attention, attracting a new type of investor with a lower risk tolerance. Just a thought.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.